Key result
NOAC monotherapy is noninferior to NOAC plus clopidogrel for major events in AF with prior DES.
Answers are grounded in this paper and cite their sources.
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
No takes yet. Share an insight, caveat, or question.
Debabrata Mukherjee (2026) studied this question. NOAC monotherapy was noninferior to NOAC plus clopidogrel for a composite of adverse clinical events at 1 year in patients with atrial fibrillation and a drug-eluting stent for ≥1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: